Risk factors for methicillin-resistant Staphylococcus aureus bacteraemia differ depending on the control group chosen

Epidemiology and Infection

Volumn 141, Issue 11, 2013, Pages 2376-2383

  Pogorzelska Maziarz, M ^a   Furuya, E Y ^b   Larson, E L ^a,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b New York Presbyterian Hospital ^*  (United States)

^c Mailman School of Public Health ^*  (United States)

Author keywords

Antibiotic resistance; bacteraemia; methicillin resistant Staphylococcus aureus; multidrug resistant infections

Indexed keywords

QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CASE CONTROL STUDY; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; DRUG USE; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION RISK; KIDNEY FAILURE; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; RISK ASSESSMENT; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTEREMIA; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ODDS RATIO; RESEARCH DESIGN; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; VIRULENCE FACTORS;

EID: 84885072093     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813000174     Document Type: Article

References (31)

1. Klevens RM, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Reports 2007; 122: 160-166.
2. Marschall J, et al. Gram-negative bacteraemia in non-ICU patients: factors associated with inadequate antibiotic therapy and impact on outcomes. Journal of Antimicrobial Chemotherapy 2008; 61: 1376-1383.
3. Filice GA, et al. Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection. Infection Control & Hospital Epidemiology 2010; 31: 365-373.
4. Gould IM. The clinical significance of methicillinresistant Staphylococcus aureus. Journal of Hospital Infection 2005; 61: 277-282.
5. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infection Control & Hospital Epidemiology 2001; 22: 99-104.
6. Rubin RJ, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerging Infectious Diseases 1999; 5: 9-17.
7. Wisplinghoff H, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clinical Infectious Diseases 2004; 39: 309-317.
8. Fowler Jr. VG, et al. Clinical identifiers of complicated Staphylococcus aureus bacteraemia. Archives of Internal Medicine 2003; 163: 2066-2072.
9. Cosgrove SE, et al. The impact of methicillin resistance in Staphylococcus aureus bacteraemia on patient outcomes: mortality, length of stay, and hospital charges. Infection Control & Hospital Epidemiology 2005; 26: 166-174.
10. Cosgrove SE, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteraemia: a meta-analysis. Clinical Infectious Diseases 2003; 36: 53-59.
11. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Medical Journal of Australia 2001; 175: 264-267.
12. Blot SI, et al. Outcome and attributable mortality in critically Ill patients with bacteraemia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Archives of Internal Medicine 2002; 162: 2229-2235.
13. Shurland S, et al. Comparison of mortality risk associated with bacteraemia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infection Control & Hospital Epidemiology 2007; 28: 273-279.
14. Libert M, et al. Risk factors for meticillin resistance and outcome of Staphylococcus aureus bloodstream infection in a Belgian university hospital. Journal of Hospital Infection 2008; 68: 17-24.
15. Romero-Vivas J, et al. Mortality associated with nosocomial bacteraemia due to methicillin-resistant Staphylococcus aureus. Clinical Infectious Diseases 1995; 21: 1417-1423.
16. Lodise Jr. TP, McKinnon PS, Rybak M. Prediction model to identify patients with Staphylococcus aureus bacteraemia at risk for methicillin resistance. Infection Control & Hospital Epidemiology 2003; 24: 655-661.
17. McHugh CG, Riley LW. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infection Control & Hospital Epidemiology 2004; 25: 425-430.
18. Ernst EJ, et al. Importance of control group selection for evaluating antimicrobial use as a risk factor for methicillin-resistant Staphylococcus aureus bacteraemia. Infection Control & Hospital Epidemiology 2005; 26: 634-637.
19. Bader MS. Staphylococcus aureus bacteraemia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain. Infection Control & Hospital Epidemiology 2006; 27: 1219-1225.
20. Bakowski E, et al. Risk factors for bacteraemia and predictors of mortality of patients with bloodstream infection with methicillin-resistant Staphylococcus aureus. American Journal of Infectious Diseases 2008; 4: 174-178.
21. Harris AD, et al. Methodological principles of casecontrol studies that analyzed risk factors for antibiotic resistance: a systematic review. Clinical Infectious Diseases 2001; 32: 1055-1061.
22. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control 2008; 36: 309-332.
23. Emori TG, et al. Accuracy of reporting nosocomial infections in intensive-care-unit patients to the National Nosocomial Infections Surveillance System: a pilot study. Infection Control & Hospital Epidemiology 1998; 19: 308-316.
24. Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 1987; 40: 373-383.
25. Overview of HCUP. (http://www.hcup-us.ahrq.gov/overview.jsp). Accessed 1 December, 2012.
26. Chen TY, et al. Poor functional status is an independent predictor of surgical site infections due to methicillinresistant Staphylococcus aureus in older adults. Journal of the American Geriatric Society 2010; 58: 527-532.
27. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. Journal of Antimicrobial Chemotherapy 2002; 49: 999-1005.
28. Harris AD, et al. Methodological principles of casecontrol studies that analyzed risk factors for antibiotic resistance: a systematic review. Clinical Infectious Disease 2001; 32: 1055-1061.
29. Tacconelli E, et al. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrobial Agents & Chemotherapy 2009; 53: 4264-4269.
30. Pujol M, et al. Nosocomial Staphylococcus aureus bacteraemia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. American Journal of Medicine 1996; 100: 509-516.
31. Bert F, et al. Association between nasal carriage of Staphylococcus aureus and infection in liver transplant recipients. Clinical Infectious Diseases 2000; 31: 1295-1299.